Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Photocoagulation for peripheral neovascularisation in diabetes.

D V Inglesby, G S Turner, W E Schulenburg

    The British Journal of Ophthalmology
    |March 1, 1985
    PubMed
    Summary

    Panretinal photocoagulation effectively prevents new vessel growth in diabetic retinopathy patients. Focal treatment is an option only for limited neovascularization with guaranteed regular follow-up.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.

    Eye (London, England)·2011
    Same author

    Temporary Character of "Fastness" of Staphylococci to Penicillin.

    British medical journal·2010
    Same author

    "Fastness" of Cocci to Penicillin.

    British medical journal·2010
    Same author

    Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2.

    The British journal of ophthalmology·2010
    Same author

    Fundus autofluorescence and Fourier-domain optical coherence tomography imaging of 10 and 20 millisecond Pascal retinal photocoagulation treatment.

    The British journal of ophthalmology·2008
    Same author

    Microvascular disease: what does the UKPDS tell us about diabetic retinopathy?

    Diabetic medicine : a journal of the British Diabetic Association·2008

    Area of Science:

    • Ophthalmology
    • Diabetic Retinopathy Research
    • Medical Treatments

    Background:

    • Diabetic retinopathy is a leading cause of vision loss.
    • Peripheral retinal neovascularization poses a significant risk of complications.
    • Effective treatment strategies are crucial for managing diabetic retinopathy.

    Purpose of the Study:

    • To evaluate the efficacy of photocoagulation in treating peripheral retinal neovascularization.
    • To compare the outcomes of panretinal vs. focal/sectorial photocoagulation.
    • To determine the risk of subsequent neovascularization after different photocoagulation approaches.

    Main Methods:

    • A study involving 90 eyes of 72 diabetic patients.
    • Treatment administered included panretinal photocoagulation, focal photocoagulation, or sectorial photocoagulation.
    • Patient outcomes were monitored for the development of new vessels.

    Main Results:

    • Panretinal photocoagulation as initial treatment resulted in infrequent development of further new vessels.
    • Focal or sectorial treatment was associated with a higher risk if not carefully selected.
    • The study highlights the importance of the initial treatment strategy.

    Conclusions:

    • Panretinal photocoagulation is a highly effective initial treatment for peripheral retinal neovascularization in diabetic patients.
    • Focal or sectorial photocoagulation should be reserved for specific cases with close monitoring.
    • This approach helps prevent vision-threatening complications of diabetic retinopathy.

    Related Experiment Videos